Back
Novo Nordisk AS Stock Price Chart

Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
18
NONOF
Novo Nordisk AS
Last Price:
$62.30
Seasonality Move:
4.5%
7 Day Trial
ALL ACCESS PASS
$
7

The Tariff-Proof Asset in Your Pocket
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NONOF is experiencing slight buying pressure.
Novo Nordisk AS Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 67.03 | Sell |
20-day SMA: | 72.89 | Sell |
50-day SMA: | 80.63 | Sell |
200-day SMA: | 108.99 | Sell |
8-day EMA: | 67.04 | Sell |
20-day EMA: | 72.37 | Sell |
50-day EMA: | 79.59 | Sell |
200-day EMA: | 99.27 | Sell |
Novo Nordisk AS Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.11 | Sell |
Relative Strength Index (14 RSI): | 26.4 | Sell |
Chaikin Money Flow: | 8996 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (67.97 - 84.17) | Sell |
Bollinger Bands (100): | (76.16 - 101.94) | Sell |
Novo Nordisk AS Technical Analysis
Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | Apr 7 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | 07 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Novo Nordisk AS Stock
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 63.14 while NONOF 8-day simple moving average is 67.03, which is a Sell signal.
-
The stock price of NONOF is 63.14 while Novo Nordisk AS 20-day SMA is 72.89, which makes it a Sell.
-
Novo Nordisk AS 50-day simple moving average is 80.63 while NONOF share price is 63.14, making it a Sell technically.
-
NONOF stock price is 63.14 and Novo Nordisk AS 200-day simple moving average is 108.99, creating a Sell signal.
NONOF Technical Analysis vs Fundamental Analysis
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Is Novo Nordisk AS a Buy or a Sell?
-
Novo Nordisk AS stock is rated a SellThe current Novo Nordisk AS [NONOF] share price is $63.14. The Score for NONOF is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Novo Nordisk AS Stock Info
Market Cap:
285.3B
Price in USD:
63.14
Share Volume:
39K
Novo Nordisk AS 52-Week Range
52-Week High:
149.55
52-Week Low:
60.67
Sell
18
Novo Nordisk AS (NONOF)
is a Sell
Novo Nordisk AS Share Price Forecast
-
What is the Novo Nordisk AS stock price today?The Novo Nordisk AS stock price is 63.14 USD today.
-
Will NONOF stock go up or go down?Novo Nordisk AS> share price is forecast to RISE/FALL based on technical indicators
-
Is Novo Nordisk AS overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Novo Nordisk AS is overvalued.
Is Novo Nordisk AS Stock a Buy?
-
Novo Nordisk AS share price is 63.14 while NONOF 8-day exponential moving average is 67.04, which is a Sell signal.
-
The stock price of NONOF is 63.14 while Novo Nordisk AS 20-day EMA is 72.37, which makes it a Sell.
-
Novo Nordisk AS 50-day exponential moving average is 79.59 while NONOF share price is 63.14, making it a Sell technically.
-
NONOF stock price is 63.14 and Novo Nordisk AS 200-day simple moving average is 99.27, creating a Sell signal.
Fundamental Analysis of Novo Nordisk AS
Is Novo Nordisk AS a good investment?
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Novo Nordisk AS
Should I short Novo Nordisk AS stock?
-
NONOF Moving Average Covergence Divergence (MACD) indicator is -5.11, suggesting Novo Nordisk AS is a Sell
-
Novo Nordisk AS Relative Strength Index (RSI) is 26.4, which suggest Novo Nordisk AS is oversold
-
The Bollinger Bands (25) for Novo Nordisk AS is (67.97 - 84.17), which suggest Novo Nordisk AS is a Sell
-
The Bollinger Bands (100) for Novo Nordisk AS is (76.16 - 101.94), which suggest Novo Nordisk AS is a Sell
* Novo Nordisk AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.